• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-1α在缺氧条件下直接调控肿瘤细胞中趋化因子受体 2 的表达。

Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia.

机构信息

Tumor Immunotherapy and Microenvironment (TIME) Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), Luxembourg, L- 1210, Luxembourg.

Department of Hemato-Oncology, Centre Hospitalier du Luxembourg, Luxembourg, L- 1210, Luxembourg.

出版信息

Sci Rep. 2024 Nov 4;14(1):26589. doi: 10.1038/s41598-024-77628-8.

DOI:10.1038/s41598-024-77628-8
PMID:39496762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535233/
Abstract

Lack of significant and durable clinical benefit from anti-cancer immunotherapies is partly due to the failure of cytotoxic immune cells to infiltrate the tumor microenvironment. Immune infiltration is predominantly dependent on the chemokine network, which is regulated in part by chemokine and atypical chemokine receptors. We investigated the impact of hypoxia in the regulation of Atypical Chemokine Receptor 2 (ACKR2), which subsequently regulates major pro-inflammatory chemokines reported to drive cytotoxic immune cells into the tumor microenvironment. Our in silico analysis showed that both murine and human ACKR2 promoters contain hypoxia response element (HRE) motifs. Murine and human colorectal, melanoma, and breast cancer cells overexpressed ACKR2 under hypoxic conditions in a HIF-1α dependent manner; as such overexpression was abrogated in melanoma cells expressing non-functional deleted HIF-1α. We also showed that decreased expression of ACKR2 in HIF-1α-deleted cells under hypoxia was associated with increased CCL5 levels. Chromatin immunoprecipitation data confirmed that ACKR2 is directly regulated by HIF-1α at its promoter in B16-F10 melanoma cells. This study provides new key elements on how hypoxia can impair immune infiltration in the tumor microenvironment.

摘要

抗癌免疫疗法缺乏显著和持久的临床获益,部分原因是细胞毒性免疫细胞未能浸润肿瘤微环境。免疫浸润主要依赖趋化因子网络,该网络部分受趋化因子和非典型趋化因子受体调节。我们研究了缺氧对非典型趋化因子受体 2 (ACKR2)调节的影响,ACKR2 随后调节主要促炎趋化因子,这些趋化因子被报道可驱动细胞毒性免疫细胞进入肿瘤微环境。我们的计算机分析表明,鼠和人 ACKR2 启动子都含有缺氧反应元件 (HRE) 基序。在缺氧条件下,鼠和人结直肠、黑色素瘤和乳腺癌细胞以 HIF-1α 依赖的方式过表达 ACKR2;因此,在表达无功能缺失 HIF-1α 的黑色素瘤细胞中,过表达被阻断。我们还表明,在缺氧下 HIF-1α 缺失细胞中 ACKR2 的表达减少与 CCL5 水平的增加有关。染色质免疫沉淀数据证实,在 B16-F10 黑色素瘤细胞中,ACKR2 可在其启动子处被 HIF-1α 直接调节。这项研究提供了新的关键因素,说明了缺氧如何损害肿瘤微环境中的免疫浸润。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/fb7bb21f6def/41598_2024_77628_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/7763c42e4a35/41598_2024_77628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/51c7770152b7/41598_2024_77628_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/42c251655d23/41598_2024_77628_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/fb7bb21f6def/41598_2024_77628_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/7763c42e4a35/41598_2024_77628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/51c7770152b7/41598_2024_77628_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/42c251655d23/41598_2024_77628_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cae/11535233/fb7bb21f6def/41598_2024_77628_Fig4_HTML.jpg

相似文献

1
Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia.缺氧诱导因子-1α在缺氧条件下直接调控肿瘤细胞中趋化因子受体 2 的表达。
Sci Rep. 2024 Nov 4;14(1):26589. doi: 10.1038/s41598-024-77628-8.
2
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy.靶向 HIF-1α转录活性可促使细胞毒性免疫效应细胞浸润黑色素瘤并改善联合免疫治疗。
Oncogene. 2021 Jul;40(28):4725-4735. doi: 10.1038/s41388-021-01846-x. Epub 2021 Jun 21.
3
Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1α.缺氧通过依赖缺氧诱导因子-1α的机制调节神经肽 B 受体的表达。
PLoS One. 2013 Dec 9;8(12):e82868. doi: 10.1371/journal.pone.0082868. eCollection 2013.
4
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.缺氧对乳腺癌组织因子途径抑制物表达的影响。
J Thromb Haemost. 2016 Feb;14(2):387-96. doi: 10.1111/jth.13206. Epub 2016 Jan 30.
5
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).缺氧诱导因子-1α/雌激素G蛋白偶联受体信号传导介导乳腺癌相关成纤维细胞(CAF)中缺氧诱导的血管内皮生长因子(VEGF)表达。
Breast Cancer Res. 2013;15(4):R64. doi: 10.1186/bcr3458.
6
ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.ERRα 通过在常氧和低氧前列腺癌细胞中直接与 HIF-1α 相互作用来增强 HIF-1 信号。
J Pathol. 2014 May;233(1):61-73. doi: 10.1002/path.4329. Epub 2014 Feb 5.
7
Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.去芹糖鬼臼毒素促进低氧肿瘤微环境中 HIF-1α 的蛋白酶体降解和免疫反应。
Phytomedicine. 2020 Nov;78:153318. doi: 10.1016/j.phymed.2020.153318. Epub 2020 Sep 1.
8
Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.信号转导及转录激活因子3是肿瘤细胞和肿瘤相关髓系细胞中缺氧诱导因子-1α RNA表达所必需的。
Mol Cancer Res. 2008 Jul;6(7):1099-105. doi: 10.1158/1541-7786.MCR-07-2177.
9
Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.趋化因子 C-C 基元受体 5 和 C-C 基元配体 5 在缺氧下促进癌细胞迁移。
Cancer Sci. 2012 May;103(5):904-12. doi: 10.1111/j.1349-7006.2012.02259.x. Epub 2012 Apr 12.
10
Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.缺氧诱导因子-1α(HIF-1α)通过在缺氧条件下上调起始因子 eIF4E1 促进乳腺癌细胞中选择性 mRNA 的帽依赖性翻译。
J Biol Chem. 2013 Jun 28;288(26):18732-42. doi: 10.1074/jbc.M113.471466. Epub 2013 May 10.

引用本文的文献

1
Targeting the atypical chemokine receptor 2 () improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.靶向非典型趋化因子受体2()可提高抗PD-1免疫疗法在黑色素瘤小鼠模型中的疗效。
Oncoimmunology. 2025 Dec;14(1):2494426. doi: 10.1080/2162402X.2025.2494426. Epub 2025 Apr 18.
2
Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunities.解析缺氧诱导因子在皮肤黑色素瘤中的作用:从机制到治疗机遇
Cell Commun Signal. 2025 Apr 9;23(1):177. doi: 10.1186/s12964-025-02173-4.

本文引用的文献

1
Chemoradiotherapy-induced ACKR2 tumor cells drive CD8 T cell senescence and cervical cancer recurrence.放化疗诱导的 ACKR2 肿瘤细胞驱动 CD8 T 细胞衰老和宫颈癌复发。
Cell Rep Med. 2024 May 21;5(5):101550. doi: 10.1016/j.xcrm.2024.101550. Epub 2024 May 8.
2
Pan-cancer analysis of the prognostic significance of expression and the related genetic/epigenetic dysregulations.泛癌症分析 表达的预后意义及相关的遗传/表观遗传失调。
Expert Rev Clin Immunol. 2024 Feb;20(2):225-236. doi: 10.1080/1744666X.2023.2274361. Epub 2024 Jan 21.
3
New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
新型趋化因子受体家族配体及其孤儿受体的鉴定——生理和临床相关性。
Front Immunol. 2023 Apr 20;14:1133394. doi: 10.3389/fimmu.2023.1133394. eCollection 2023.
4
CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway.CXCL14 通过 ACKR2 依赖性信号通路促进非小细胞肺癌转移。
Int J Biol Sci. 2023 Feb 27;19(5):1455-1470. doi: 10.7150/ijbs.79438. eCollection 2023.
5
Atypical chemokine receptors: emerging therapeutic targets in cancer.非典型趋化因子受体:癌症治疗的新靶点。
Trends Pharmacol Sci. 2022 Dec;43(12):1085-1097. doi: 10.1016/j.tips.2022.09.009. Epub 2022 Oct 26.
6
The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?非典型趋化因子受体 D6(ACKR2)在生理和病理条件下的作用;朋友、敌人,还是两者兼有?
Front Immunol. 2022 May 23;13:861931. doi: 10.3389/fimmu.2022.861931. eCollection 2022.
7
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.缺氧诱导因子:缺氧肿瘤免疫逃逸的主调控因子。
J Hematol Oncol. 2022 Jun 3;15(1):77. doi: 10.1186/s13045-022-01292-6.
8
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.GPR182 通过清除趋化因子限制小鼠黑色素瘤模型中的抗肿瘤免疫。
Nat Commun. 2022 Jan 10;13(1):97. doi: 10.1038/s41467-021-27658-x.
9
Hypoxia as a driver of resistance to immunotherapy.缺氧作为免疫治疗抵抗的驱动因素。
Drug Resist Updat. 2021 Dec;59:100787. doi: 10.1016/j.drup.2021.100787. Epub 2021 Nov 18.
10
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy.靶向 HIF-1α转录活性可促使细胞毒性免疫效应细胞浸润黑色素瘤并改善联合免疫治疗。
Oncogene. 2021 Jul;40(28):4725-4735. doi: 10.1038/s41388-021-01846-x. Epub 2021 Jun 21.